Participants
| Role | Name | HCID | Charge |
|---|
| Reactant | Sodium Hydroxide | HCID 14798 | — |
| Reactant | Hydrogen chloride-ethyl acetate | HCID 21866389 | — |
| Reactant | HCID 23156171 | HCID 23156171 | — |
| Solvent | Chloroform | HCID 6212 | — |
| Product | HCID 69439940 | HCID 69439940 | 60% |
Reaction Steps
A solution of 4-[4-(2-ethyl-5,7-dimethyl-3H-imidazo[4,5-b]pyridin-3-ylmethyl)phenylamino]-1-[1-(tert-butoxycarbonyl)piperidin-4-ylcarbonyl]piperidine (0.311 g, 0.54 mmol) obtained in Step 1 in chloroform (5.0 mL) was added with a 4 mol/L hydrogen chloride-ethyl acetate solution (2.0 mL) followed by stirring at room temperature for 1 hour. The reaction mixture was added with a 2 mol/L aqueous sodium hydroxide solution to control the pH to 12 and extracted with chloroform three times. The organic layer was dried over anhydrous magnesium sulfate and concentrated under reduced pressure. The obtained crystals were added with diisopropyl ether followed by stirring under reflux for 1 hour. The crystals were collected by filtration and dried under reduced pressure to obtain Compound 147 (0.153 g, 0.32 mmol, 60%).
Provenance & Evidence
| DOI | 10.6084/m9.figshare.5104873.v1 |
|---|
| Patent number | US08507484B2 |
|---|
| Source dataset | uspto-grants-2013_08 |
|---|
| ORD ID | ord-9b00533878a84ecf941baad7edd4603f |
|---|
| Source note | uspto-grants-2013_08 |
|---|